FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075390410> ?p ?o ?g. }

• W2075390410 endingPage "309" @default.
• W2075390410 startingPage "299" @default.
• W2075390410 abstract "Peanut allergy is a life-threatening condition for which new efficient and safe treatment is expected. We evaluated epicutaneous immunotherapy (EPIT) as a new alternative treatment for peanut allergy in sensitized mice.Sixty BALB/c mice were sensitized by gavages with peanut protein extract (PPE) mixed with cholera toxin. An epicutaneous delivery system, coated with 100 μg PPE (Viaskin®, DBV Technologies, Paris, France), was applied to intact skin every week during 48 h (EPIT; n = 20). This group was compared with sensitized mice treated with subcutaneous immunotherapy (SCIT; n = 20), untreated sensitized mice (sham, n = 20), and naive mice (naive; n = 20). After the 8-week treatment, a histamine release test, airway hyperreactivity measurement by plethysmography, and a resistance-compliance measurement after the challenge were performed. Blood and bronchoalveolar lavage were sampled for serology, cytokines, and cytology.Specific IgE (sIgE) increased after sensitization in the EPIT (0.26 μg/ml) and SCIT (0.21 μg/ml) groups and decreased after treatment (0.09 μg/ml, p < 0.001 and 0.06 μg/ml, p < 0.001, respectively). The IgG1/IgG2a ratio decreased in the EPIT and SCIT groups versus the sham group (3.7; p < 0.001 and 2.7; p < 0.01 and 15.1, respectively). At the higher metacholine concentration, enhanced pause values were lower in the EPIT and SCIT groups than in the sham group (7.29, 6.74, and 10.99, p < 0.01, respectively), and did not differ from that of the naive group (5.06). Resistance-compliance was reversed in the treated groups versus the sham group (p < 0.001). IL-4, IL-5, IL-13, eotaxin, and eosinophils were reduced in the BAL of the EPIT and SCIT groups versus the sham group (p < 0.001).In peanut-sensitized mice, based on biological and physiological responses, EPIT is as efficient as subcutaneous treatment which is the reference method in immunotherapy." @default.
• W2075390410 created "2016-06-24" @default.
• W2075390410 creator A5012219277 @default.
• W2075390410 creator A5027245152 @default.
• W2075390410 creator A5053106594 @default.
• W2075390410 creator A5065124015 @default.
• W2075390410 creator A5078301995 @default.
• W2075390410 creator A5078980402 @default.
• W2075390410 date "2010-10-20" @default.
• W2075390410 modified "2023-10-17" @default.
• W2075390410 title "Epicutaneous Immunotherapy Using a New Epicutaneous Delivery System in Mice Sensitized to Peanuts" @default.
• W2075390410 cites W1527104786 @default.
• W2075390410 cites W1968888942 @default.
• W2075390410 cites W1983749274 @default.
• W2075390410 cites W1984632296 @default.
• W2075390410 cites W1988733403 @default.
• W2075390410 cites W1991697750 @default.
• W2075390410 cites W1992674508 @default.
• W2075390410 cites W1992703605 @default.
• W2075390410 cites W1994572937 @default.
• W2075390410 cites W1996219390 @default.
• W2075390410 cites W2001834436 @default.
• W2075390410 cites W2002072394 @default.
• W2075390410 cites W2012264292 @default.
• W2075390410 cites W2018931846 @default.
• W2075390410 cites W2030014527 @default.
• W2075390410 cites W2040343402 @default.
• W2075390410 cites W2043554125 @default.
• W2075390410 cites W2050387062 @default.
• W2075390410 cites W2050928602 @default.
• W2075390410 cites W2058382969 @default.
• W2075390410 cites W2073878653 @default.
• W2075390410 cites W2074422624 @default.
• W2075390410 cites W2075982355 @default.
• W2075390410 cites W2078338380 @default.
• W2075390410 cites W2087542023 @default.
• W2075390410 cites W2096279219 @default.
• W2075390410 cites W2098403531 @default.
• W2075390410 cites W2115516890 @default.
• W2075390410 cites W2126118351 @default.
• W2075390410 cites W2141701917 @default.
• W2075390410 cites W2147284831 @default.
• W2075390410 cites W2153231621 @default.
• W2075390410 cites W2153592178 @default.
• W2075390410 cites W2155385634 @default.
• W2075390410 cites W2158043711 @default.
• W2075390410 cites W2158784094 @default.
• W2075390410 cites W2327922071 @default.
• W2075390410 doi "https://doi.org/10.1159/000321822" @default.
• W2075390410 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20962535" @default.
• W2075390410 hasPublicationYear "2010" @default.
• W2075390410 type Work @default.
• W2075390410 sameAs 2075390410 @default.
• W2075390410 citedByCount "103" @default.
• W2075390410 countsByYear W20753904102012 @default.
• W2075390410 countsByYear W20753904102013 @default.
• W2075390410 countsByYear W20753904102014 @default.
• W2075390410 countsByYear W20753904102015 @default.
• W2075390410 countsByYear W20753904102016 @default.
• W2075390410 countsByYear W20753904102017 @default.
• W2075390410 countsByYear W20753904102018 @default.
• W2075390410 countsByYear W20753904102019 @default.
• W2075390410 countsByYear W20753904102020 @default.
• W2075390410 countsByYear W20753904102021 @default.
• W2075390410 countsByYear W20753904102022 @default.
• W2075390410 countsByYear W20753904102023 @default.
• W2075390410 crossrefType "journal-article" @default.
• W2075390410 hasAuthorship W2075390410A5012219277 @default.
• W2075390410 hasAuthorship W2075390410A5027245152 @default.
• W2075390410 hasAuthorship W2075390410A5053106594 @default.
• W2075390410 hasAuthorship W2075390410A5065124015 @default.
• W2075390410 hasAuthorship W2075390410A5078301995 @default.
• W2075390410 hasAuthorship W2075390410A5078980402 @default.
• W2075390410 hasConcept C1122143 @default.
• W2075390410 hasConcept C126322002 @default.
• W2075390410 hasConcept C141105273 @default.
• W2075390410 hasConcept C159654299 @default.
• W2075390410 hasConcept C203014093 @default.
• W2075390410 hasConcept C207480886 @default.
• W2075390410 hasConcept C2776217527 @default.
• W2075390410 hasConcept C2777701055 @default.
• W2075390410 hasConcept C2777714996 @default.
• W2075390410 hasConcept C2777961210 @default.
• W2075390410 hasConcept C71924100 @default.
• W2075390410 hasConcept C8891405 @default.
• W2075390410 hasConceptScore W2075390410C1122143 @default.
• W2075390410 hasConceptScore W2075390410C126322002 @default.
• W2075390410 hasConceptScore W2075390410C141105273 @default.
• W2075390410 hasConceptScore W2075390410C159654299 @default.
• W2075390410 hasConceptScore W2075390410C203014093 @default.
• W2075390410 hasConceptScore W2075390410C207480886 @default.
• W2075390410 hasConceptScore W2075390410C2776217527 @default.
• W2075390410 hasConceptScore W2075390410C2777701055 @default.
• W2075390410 hasConceptScore W2075390410C2777714996 @default.
• W2075390410 hasConceptScore W2075390410C2777961210 @default.
• W2075390410 hasConceptScore W2075390410C71924100 @default.
• W2075390410 hasConceptScore W2075390410C8891405 @default.
• W2075390410 hasIssue "4" @default.

• next